Structure, Function, and Drug Interactions of Neurotransmitter Transporters in the Postgenomic Era

Annual Review of Pharmacology and Toxicology

Volumn 56, Issue , 2016, Pages 385-402

  Omote, Hiroshi ^a   Miyaji, Takaaki ^b   Hiasa, Miki ^a   Juge, Narinobu ^b   Moriyama, Yoshinori ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Purification; Reconstitution; SLC17; Transporter; Vesicular neurotransmitter transporter

Indexed keywords

CHLORIDE; EXCITATORY AMINO ACID TRANSPORTER; ORGANIC ANION TRANSPORTER; SIALIN; SODIUM PHOSPHATE COTRANSPORTER 1; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR NEUROTRANSMITTER TRANSPORTER; VESICULAR POLYAMINE TRANSPORTER;

ARTICLE; BIOENERGY; CHLORIDE TRANSPORT; DRUG INTERACTION; GENOMICS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; DRUG INTERACTIONS; HUMANS; VESICULAR NEUROTRANSMITTER TRANSPORT PROTEINS;

EID: 84954117384     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-010814-124816     Document Type: Article

References (105)

1. Chaudhry FA, Boulland JL, Jenstad M, Bredahl MK, Edwards RH. 2008. Pharmacology of neurotransmitter transport into secretory vesicles. Handb. Exp. Pharmacol. 184:77-106
2. Omote H, Miyaji T, Juge N, Moriyama Y. 2011. Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport. Biochemistry 50(25):5558-65
3. Omote H, Moriyama Y. 2013. Vesicular neurotransmitter transporters: An approach for studying transporters with purified proteins. Physiology 28(1):39-50
4. Reimer RJ. 2013. SLC17: A functionally diverse family of organic anion transporters. Mol. Asp. Med. 34(2-3):350-59
5. Eiden LE, Schäfer MKH, Weihe E, Schutz B. 2004. The vesicular amine transporter family (SLC18): Amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflüg. Arch. 447(5):636-40
6. HiasaM,MiyajiT,Haruna Y,TakeuchiT,Harada Y, et al. 2014. Identification of a mammalian vesicular polyamine transporter. Sci. Rep. 4:6836
7. Gasnier B. 2003. The SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids. Pflüg. Arch. 447(5):756-59
8. Juge N, Omote H, Moriyama Y. 2013. Vesicular GABA transporter (VGAT) transports alanine. J. Neurochem. 127(4):482-86
9. El Mestikawy S, Wallén-Mackenzie A, Fortin GM, Descarries L, Trudeau LE. 2011. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat. Rev. Neurosci. 12(4):204-16
10. Herzog E, Gilchrist J, Gras C, Muzerelle A, Ravassard P, et al. 2004. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 123(4):983-1002
11. Miyazaki T, Fukaya M, Shimizu H, Watanabe M. 2003. Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum. Eur. J. Neurosci. 17(12):2563-72
12. HayashiM,YamadaH,Uehara S,MorimotoR,MuroyamaA, et al. 2003. Secretory granule-mediated cosecretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islet of Langerhans. J. Biol. Chem. 278(3):1966-74
13. Moriyama Y, Yamamoto A. 2004. Glutamatergic chemical transmission: Look! Here, there, and anywhere. J. Biochem. 135(2):155-63
14. Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, et al. 2006. Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 25(18):4175-86
15. Fremeau RT, Kam K, Qureshi T, Johnson J, Copenhagen DR, et al. 2004. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304(5678):1815-19
16. Moechars D, Weston MC, Leo S, Callaerts-Vegh Z, Goris I, et al. 2006. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J. Neurosci. 26(46):12055-66
17. Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, et al. 2004. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. PNAS 101(18):7158-63
18. Naito S, Ueda T. 1985. Characterization of glutamate uptake into synaptic vesicles. J. Neurochem. 44(1):99-109
19. Tabb JS, Kish PE, Van Dyke R, Ueda T. 1992. Glutamate transport into synaptic vesicles: roles of membrane potential, pH gradient, and intravesicular pH. J. Biol. Chem. 267(22):15412-18
20. Moriyama Y, Yamamoto A. 1995. Vesicular L-glutamate transporter in microvesicles from bovine pineal glands. J. Biol. Chem. 270(38):22314-20
21. Takamori S, Rhee JS, Rosenmund C, Jahn R. 2000. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407(6801):189-94
22. Bellocchio EE, Reimer RJ, Fremeau RT Jr., Edwards RH. 2000. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289(5481):957-60
23. El Mestikawy S, Wallén-Mackenzie A, Fortin GM, Descarries L, Trudeau LE. 2011. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat. Rev. Neurosci. 12(4):204-16
24. Juge N, Yoshida Y, Yatsushiro S, Omote H, Moriyama Y. 2006. Vesicular glutamate transporter contains two independent transport machineries. J. Biol. Chem. 281(51):39499-506
25. Hnasko TS, Chuhma N, Zhang H, Goh GY, Sulzer D, et al. 2010. Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 65(5):643-56
26. Hnasko TS, Edwards RH. 2012. Neurotransmitter corelease: mechanism and physiological role. Annu. Rev. Physiol. 74:225-43
27. Juge N, Gray JA, Omote H, Miyaji T, Inoue T, et al. 2010. Metabolic control of vesicular glutamate transport and release. Neuron 68(1):99-112
28. Burger PM,MehlE,Cameron PL,Maycox PR, BaumertM, et al. 1989. Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate. Neuron 3(6):715-20
29. Johnson RG, Scarpa A. 1979. Protonmotive force and catecholamine transport in isolated chromaffin granules. J. Biol. Chem. 254(10):3750-60
30. Russell JT. 1984. -pH, H+ diffusion potentials, and Mg2+ ATPase in neurosecretory vesicles isolated from bovine neurohypophyses. J. Biol. Chem. 259(15):9496-507
31. Werner A, Moore ML, Mantei N, Biber J, Semenza G, Murer H. 1991. Cloning and expression of cDNA for a Na/Pi cotransport system of kidney cortex. PNAS 88(21):9608-12
32. Guo B, Jin Y, Wussler C, Blancaflor EB, Motes CM, Versaw WK. 2008. Functional analysis of the Arabidopsis PHT4 family of intracellular phosphate transporters. New Phytol. 177(4):889-98
33. Pavón LR, Lundh F, Lundin B, Mishra A, Persson BL, Spetea C. 2008. Arabidopsis ANTR1 is a thylakoidNa +-dependent phosphate transporter: functional characterization in Escherichia coli. J. Biol. Chem. 283(20):13520-27
34. Pavón LR,Karlsson PM, Carlsson J, Samyn D, Persson B, et al. 2010. Functionally important amino acids in the Arabidopsis thylakoid phosphate transporter: homology modeling and site-directed mutagenesis. Biochemistry 49(30):6430-39
35. Miyaji T, Kuromori T, Takeuchi Y, Yamaji N, Yokosho K, et al. 2015. AtPHT4;4 is a chloroplastlocalized ascorbate transporter in Arabidopsis. Nat. Commun. 6:5925
36. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S. 2003. Structure and mechanism of the lactose permease of Escherichia coli. Science 301(5633):610-15
37. Huang Y, Lemieux MJ, Song J, Auer M,Wang DN. 2003. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301(5633):616-20
38. Miyaji T, Echigo N, Hiasa M, Senoh S, Omote H, Moriyama Y. 2008. Identification of a vesicular aspartate transporter. PNAS 105(33):11720-24
39. Almqvist J, Huang Y, Laaksonen A, Wang DN, Hovmöller S. 2007. Docking and homology modeling explain inhibition of the human vesicular glutamate transporters. Protein Sci. 16(9):1819-29
40. Hartinger J, Jahn R. 1993. An anion binding site that regulates the glutamate transporter of synaptic vesicles. J. Biol. Chem. 268(31):23122-27
41. Wolosker H, de Souza DO, de Meis L. 1996. Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient. J. Biol. Chem. 271(20):11726-31
42. Schenck S, Wojcik SM, Brose N, Takamori S. 2009. A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles. Nat. Neurosci. 12(2):156-62
43. Busch AE, Schuster A, Waldegger S, Wagner CA, Zempel G, et al. 1996. Expression of a renal type I sodium/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. PNAS 93(11):5347-51
44. Bröer S, Schuster A, Wagner CA, Bröer A, Forster I, et al. 1998. Chloride conductance and Pi transport are separate functions induced by the expression of NaPi-1 in Xenopus oocytes. J. Membr. Biol. 164(1):71-77
45. Preobraschenski J, Zander JF, Suzuki T, Ahnert-Hilger G, Jahn R. 2014. Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter. Neuron 84(6):1287-301
46. Achilles K,Okabe A, IkedaM, Shimizu-Okabe C, Yamada J, et al. 2007. Kinetic properties of Cl uptake mediated by Na+-dependent K+-2Cl cotransport in immature rat neocortical neurons. J. Neurosci. 27(32):8616-27
47. Vining EP. 1999. Clinical efficacy of the ketogenic diet. Epilepsy Res. 37(3):181-90
48. Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, et al. 2000. Inhibition of glutamate uptake into synaptic vesicles of rat brain by themetabolites accumulating inmaple syrup urine disease. J. Neurol. Sci. 181(1-2):44-49
49. Thompson CM, Davis E, Carrigan CN, Cox HD, Bridges RJ, et al. 2005. Inhibitor of the glutamate vesicular transporter (VGLUT). Curr. Med. Chem. 12(18):2041-56
50. Roseth S, Fykse EM, Fonnum F. 1998. Uptake of L-glutamate into synaptic vesicles: competitive inhibition by dyes with biphenyl and amino-and sulphonic acid-substituted naphthyl groups. Biochem. Pharmacol. 56(9):1243-49
51. Tamura Y, OgitaK,UedaT. 2014. A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow. Neurochem. Res. 39(1):117-28
52. Ogita K,Hirata K, Bole DG, Yoshida S, Tamura Y, et al. 2001. Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal. J. Neurochem. 77(1):34-42
53. Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ. 1998. Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Neuropharmacology 37(7):839-46
54. Ganong AH, Lanthorn TH, Cotman CW. 1983. Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res. 273(1):170-74
55. Verheijen FW, Verbeek E, Aula N, Beerens CE, Havelaar AC, et al. 1999. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat. Genet. 23(4):462-65
56. Morin P, Sagne C, Gasnier B. 2004. Functional characterization of wild-type and mutant human sialin. EMBO J. 23(23):4560-70
57. Wreden CC, Wlizla M, Reimer RJ. 2005. Varied mechanisms underlie the free sialic acid storage disorders. J. Biol. Chem. 280(2):1408-16
58. Haataja L, Parkkola R, Sonninen P, Vanhanen SL, Schleutker J, et al. 1994. Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics 25(5):238-44
59. Alajoki L, Varho T, Posti K, Aula P, Korhonen T. 2004. Neurocognitive profiles in Salla disease. Dev. Med. Child. Neurol. 46(12):832-37
60. Aula P, Gahl WA. 2001. Disorders of free sialic acid storage. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 5109-20. New York: McGraw-Hill
61. Nadler JV, Vaca KW,White WF, Lynch GS, Cotman CW. 1976. Aspartate and glutamate as possible transmitters of excitatory hippocampal afferents. Nature 260(5551):538-40
62. Yatsushiro S, Yamada H, Kozaki S, Kumon H, Michibata H, et al. 1997. L-aspartate but not the D form is secreted through microvesicle-mediated exocytosis and is sequestered through Na+-dependent transporter in rat pinealocytes. J. Neurochem. 69(1):340-47
63. Gundersen V, Chaudhry FA, Bjaalie JG, Fonnum F, Ottersen OP, Storm-Mathisen J. 1998. Synaptic vesicular localization and exocytosis of L-aspartate in excitatory nerve terminals. J. Neurosci. 18(16):6059-70
64. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels. Pharmacol. Rev. 51(1):7-61
65. Bliss TVP, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407):31-39
66. Aula N, Kopra O, Jalanko A, Peltonen L 2004. Sialin expression in the CNS implicates extralysosomal function in neurons. Neurobiol. Dis. 15(2):251-61
67. Miyaji T, Omote H, Moriyama Y. 2011. Functional characterization of vesicular excitatory amino acid transport by human sialin. J. Neurochem. 119(1):1-5
68. Lodder-Gadaczek J, Gieselmann V, Eckhardt M. 2013. Vesicular uptake of N-acetylaspartylglutamate is catalysed by sialin (SLC17A5). Biochem. J. 454(1):31-38
69. Prolo LM, Vogel H, Reimer RJ. 2009. The lysosomal sialic acid transporter sialin is required for normal CNS myelination. J. Neurosci. 29(49):15355-65
70. Morland C, Nordengen K, Larsson M, Prolo LM, Farzampour Z, et al. 2013. Vesicular uptake and exocytosis of L-aspartate is independent of sialin. FASEB J. 27(3):1264-74
71. Burnstock G. 2007. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87(2):659-797
72. Winkler H, Carmichael SW. 1982. The chromaffin granule. In The Secretory Granule, ed. AMPoisner, JM Trifaŕo, pp. 3-79. Amsterdam: Elsevier Biomedical
73. Johnson RG. 1988. Accumulation of biological amines into chromaffin granules: A model for hormone and neurotransmitter transport. Physiol. Rev. 68(1):232-307
74. Hutton JC, Penn EJ, Peshavaria M. 1983. Low-molecular-weight constituents of isolated insulinsecretory granules: bivalent cations, adenine nucleotides and inorganic phosphate. Biochem. J. 210(2):297-305
75. Kostron H, Winkler H, Peer LJ, König P. 1977. Uptake of adenosine triphosphate by isolated adrenal chromaffin granules: A carrier-mediated transport. Neuroscience 2(1):159-66
76. Weber A, Winkler H. 1981. Specificity and mechanism of nucleotide uptake by adrenal chromaffin granules. Neuroscience 6(11):2269-76
77. Weber A, Westhead EW, Winkler H. 1983. Specificity and properties of the nucleotide carrier in chromaffin granules from bovine adrenal medulla. Biochem. J. 210(3):789-94
78. Rudnick G. 2008. Vesicular ATP transport is a hard (V)NUT to crack. PNAS 105(16):5949-50
79. Sawada K, Echigo N, Juge N, Miyaji T, Otsuka M, et al. 2008. Identification of a vesicular nucleotide transporter. PNAS 105(15):5683-86
80. Miyaji T, Sawada K, Omote H, Moriyama Y. 2011. Divalent cation transport by vesicular nucleotide transporter. J. Biol. Chem. 286(50):42881-87
81. Hiasa M, Togawa N, Miyaji T, Omote H, Yamamoto A, Moriyama Y. 2014. Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets. Physiol. Rep. 2(6):e12034
82. Kato Y, Omote H, Miyaji T. 2013. Inhibitors of ATP release inhibit vesicular nucleotide transporter. Biol. Pharm. Bull. 36(11):1688-91
83. Larsson M, Sawada K, Morland C, Hiasa M, Ormel L, et al. 2012. Functional and anatomical identification of a vesicular transporter mediating neuronal ATP release. Cereb. Cortex 22(5):1203-14
84. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, et al. 2003. Storage and release of ATP from astrocytes in culture. J. Biol. Chem. 278(2):1354-62
85. Pangrsic T, Potokar M, Stenovec M, Kreft M, Fabbretti E, et al. 2007. Exocytotic release of ATP from cultured astrocytes. J. Biol. Chem. 282(39):28749-58
86. Zhang Z, Chen G, ZhouW, Song A, Xu T, et al. 2007. Regulated ATP release from astrocytes through lysosome exocytosis. Nat. Cell Biol. 9(8):945-53
87. Iwatsuki K, Ichikawa R, Hiasa M, Moriyama Y, Torii K, et al. 2009. Identification of the vesicular nucleotide transporter (VNUT) in taste cells. Biochem. Biophys. Res. Commun. 388(1):1-5
88. Mihara H, Boudaka A, Sugiyama T, Moriyama Y, Tominaga M. 2011. Transient receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and ATP release in mouse oesophageal keratinocytes. J. Physiol. 589:3471-82
89. Wolf-Johnston AS, Hanna-Mitchell AT, Buffington CA, Shinde S, Roppolo JR, et al. 2012. Alterations in the non-neuronal acetylcholine synthesis and release machinery in esophageal epithelium. Life Sci. 91(21-22):1065-69
90. Vessey KA, Fletcher EL. 2012. Rod and cone pathway signalling is altered in the P2X7 receptor knock out mouse. PLOS ONE 7:e29990
91. Haanes KA, Novak I. 2010. ATP storage and uptake by isolated pancreatic zymogen granules. Biochem. J. 429(2):303-11
92. Geisler JC, Corbin KL, Li Q, Feranchak AP, Nunemaker CS, Li C. 2013. Vesicular nucleotide transporter-mediated ATP release regulates insulin secretion. Endocrinology 154(2):675-84
93. Tokunaga A, Tsukimoto M, Harada H, Moriyama Y, Kojima S. 2010. Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation. J. Biol. Chem. 285(23):17406-16
94. Sakaki H, TsukimotoM, Harada H,Moriyama Y, Kojima S. 2013. Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor. PLOS ONE 8:e59778
95. Sesma JI, Kreda SM, Okada SF, van Heusden C, Moussa L, et al. 2013. Vesicular nucleotide transporter regulates the nucleotide content in airway epithelial mucin granules. Am. J. Physiol. Cell Physiol. 304(10):C976-84
96. Sathe MN, Woo K, Kresge C, Bugde A, Luby-Phelps K, et al. 2011. Regulation of purinergic signaling in biliary epithelial cells by exocytosis of SLC17A9-dependent ATP-enriched vesicles. J. Biol. Chem. 286(28):25363-76
97. Shinozaki Y, Nomura M, Iwatsuki K, Moriyama Y, Gachet C, Koizumi S. 2014. Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission. Sci. Rep. 4:4329
98. Sakamoto S, Miyaji T, Hiasa M, Ichikawa R, Uematsu A, et al. 2014. Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity. Sci. Rep. 4:6689
99. Uchino H, Tamai I, Yamashita K, Minemoto Y, Sai Y, et al. 2000. p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem. Biophys. Res. Commun. 270(1):254-59
100. Iharada M, Miyaji T, Fujimoto T, Hiasa M, Anzai N, et al. 2010. Type 1 sodium-dependent phosphate transporter (SLC17A1 protein) is a Cl-dependent urate exporter. J. Biol. Chem. 285(34):26107-13
101. Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, et al. 2009. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLOS ONE 4(11):e7729
102. Togawa N, Miyaji T, Izawa S, Omote H, Moriyama Y. 2012. Na+/phosphate co-transporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am. J. Physiol. Cell Physiol. 302(11):C1652-60
103. Ogden KK, Traynelis SF. 2011. New advances in NMDA receptor pharmacology. Trends Pharmacol. Sci. 32:726-33
104. Jacobsson JA, Stephansson O, Fredriksson R. 2010. C6ORF192 forms a unique evolutionary branch among solute carriers (SLC16, SLC17, and SLC18) and is abundantly expressed in several brain regions. J. Mol. Neurosci. 41(2):230-42
105. Juge N, Moriyama S, Miyaji T, Kawakami M, Iwai H, et al. 2015. Plasmodium falciparum chloroquine resistance transporter is a H+-coupled polyspecific nutrient and drug exporter. PNAS 112(11):3356-61